Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

Kodiak Sciences (KOD) stock gains as J.P. Morgan upgrades, arguing that a recent trial readout from Roche (RHHBY) derisked the firm's eye drug KSI-101. Read more here.

Software-as-a-Service (SaaS) applications are the engine of modern business. From email and file sharing to customer data and finance, they keep teams moving fast and staying connected. But here’s the ...

Is your SIEM strategy doing enough to protect your data? In a world where threats move fast, integrating your Security Information and Event Management (SIEM) systems with Veeam Data Platform can give ...